The Micro-Immunotherapy Medicine 2LPAPI<sup>®</sup> Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells.

Cancers (Basel) · 2024 · PMC11010933 · PMID 38611099

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Overall, these results revealed that actives from the 2LPAPI can induce the stimulation of secretion of IL-6 and influence the levels of IFN-γ and IP-10 in the experimental conditions tested, even if the changes induced by the 2LPAPI capsules on IFN-γ did not reach statistical significance. 3.4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.